JL

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences

Cellectar Biosciences Pipeline

DrugIndicationPhase
Iopofosine I 131 (CLR 131)Relapsed/Refractory Multiple MyelomaPhase 3